{"id":3890,"date":"2017-10-24T07:11:27","date_gmt":"2017-10-24T07:11:27","guid":{"rendered":"https:\/\/www.nanexa.com\/mfn_news\/kommunike-fran-extra-bolagsstamma-i-nanexa-ab-publ-den-23-oktober-2017\/"},"modified":"2017-10-24T07:11:27","modified_gmt":"2017-10-24T07:11:27","slug":"kommunike-fran-extra-bolagsstamma-i-nanexa-ab-publ-den-23-oktober-2017","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/kommunike-fran-extra-bolagsstamma-i-nanexa-ab-publ-den-23-oktober-2017\/","title":{"rendered":"Kommunik\u00e9 fr\u00e5n extra bolagsst\u00e4mma i Nanexa AB (publ) den 23 oktober 2017"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong>Nanexa AB (publ) h\u00f6ll den 23 oktober 2017 en extra bolagsst\u00e4mma.<\/strong><\/div>\n<p>Vid st\u00e4mman beslutades att \u00e4ndra<\/p>\n<p>bolagsordningen enligt styrelsens f\u00f6rslag och d\u00e4rigenom \u00f6ka gr\u00e4nserna f\u00f6r aktiekapitalet fr\u00e5n 975 000<\/p>\n<p>kronor till 3 900 000 kronor och \u00f6ka gr\u00e4nsen f\u00f6r antalet aktier till som l\u00e4gst 7 500 000 och h\u00f6gst 30 000<\/p>\n<p>000 st. Dessutom beslutade st\u00e4mman att genomf\u00f6ra en f\u00f6retr\u00e4desemission av units enligt styrelsens<\/p>\n<p>f\u00f6rslag som avser tillf\u00f6ra bolaget cirka 22,9 MSEK f\u00f6re emissionskostnader. Detta medf\u00f6r att bolagets<\/p>\n<p>aktiekapital kan \u00f6kas med h\u00f6gst 493 422,42 kronor genom utgivande av h\u00f6gst 3 812 527 aktier. Beslutet<\/p>\n<p>medf\u00f6r vidare att h\u00f6gst 3 812 527 teckningsoptioner ges ut med r\u00e4tt att teckna 3 812 527 aktier. Bolagets<\/p>\n<p>aktiekapital kan genom utnyttjande av teckningsoptionerna komma att \u00f6kas med h\u00f6gst 493 422,42<\/p>\n<p>kronor.<\/p>\n<p>F\u00f6r varje befintlig aktie erh\u00e5lls en teckningsr\u00e4tt. Tv\u00e5 (2) befintliga aktier i Bolaget ber\u00e4ttigar teckning av en<\/p>\n<p>(1) Unit f\u00f6r 6 SEK. En (1) Unit best\u00e5r av en aktie och en vederlagsfri teckningsoption av serie TO 1. St\u00f6rre<\/p>\n<p>teckning \u00e4n vad erh\u00e5llna r\u00e4tter ger r\u00e4tt till kan inl\u00e4mnas. Teckning utan f\u00f6retr\u00e4de \u00e4r ocks\u00e5 m\u00f6jlig.<\/p>\n<p>Anm\u00e4lan till teckning av units med st\u00f6d av unitr\u00e4tter ska ske genom samtidig kontant betalning under<\/p>\n<p>tiden fr\u00e5n och med den 6 november 2017 till och med den 20 november 2017. Unitr\u00e4tterna \u00e4r fritt<\/p>\n<p>\u00f6verl\u00e5tbara och kommer att handlas p\u00e5 AktieTorget fr\u00e5n och med den 6 november 2017 till och med den<\/p>\n<p>16 november 2017.<\/p>\n<p>F\u00f6r det fall inte samtliga nya units tecknas med f\u00f6retr\u00e4desr\u00e4tt ska styrelsen, inom ramen f\u00f6r emissionens<\/p>\n<p>h\u00f6gsta belopp, besluta om f\u00f6rdelning av units som inte tecknats med f\u00f6retr\u00e4desr\u00e4tt. S\u00e5dan f\u00f6rdelning ska<\/p>\n<p>i f\u00f6rsta hand ske till tecknare som tecknat units med st\u00f6d av unitr\u00e4tter, oavsett om de var aktie\u00e4gare p\u00e5<\/p>\n<p>avst\u00e4mningsdagen eller inte, och vid \u00f6verteckning i f\u00f6rh\u00e5llande till det antal units som s\u00e5dana personer<\/p>\n<p>tecknat i emissionen och, i den m\u00e5n detta inte kan ske, genom lottning. I andra hand ska f\u00f6rdelning ske till<\/p>\n<p>\u00f6vriga som tecknat units utan st\u00f6d av unitr\u00e4tter och, vid \u00f6verteckning, i f\u00f6rh\u00e5llande till det antal units<\/p>\n<p>som s\u00e5dana personer anm\u00e4lt f\u00f6r teckning, och i den m\u00e5n detta inte kan ske, genom lottning.<\/p>\n<p>Emissionslikviden skall framf\u00f6rallt anv\u00e4ndas till vidareutveckling, verifiering och marknadsf\u00f6ring av drugdelivery<\/p>\n<p>plattformen PharmaShell@.<\/p>\n<p>Uppsala den 24 oktober 2017<\/p>\n<p>Nanexa AB (publ)<\/p>\n<p>Styrelsen<\/p>\n<p>F\u00f6r ytterligare information:<\/p>\n<p>Nanexa AB (publ)<\/p>\n<p>David Westberg, VD<\/p>\n<p>Tel. 0709-42 83 03<\/p>\n<p>E-mail: david.westberg@nanexa.se<\/p>\n<p>www.nanexa.com<\/p>\n<p>Om Nanexa AB (publ)<\/p>\n<p>Nanexa AB \u00e4r ett nanoteknologiskt drug delivery-f\u00f6retag som fokuserar verksamheten p\u00e5 utvecklingen av<\/p>\n<p>PharmaShell\u00ae som \u00e4r ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor potential inom<\/p>\n<p>ett flertal indikationsomr\u00e5den. Inom ramen f\u00f6r PharmaShell\u00ae har Nanexa samarbetsavtal med bland andra<\/p>\n<p>AstraZeneca.<\/p>\n<div class=\"mfn-footer mfn-attachment\">\n<p><strong>Bifogade filer<\/strong><\/p>\n<hr\/>\n<p><a href=\"http:\/\/mb.cision.com\/Main\/12591\/2374093\/740630.pdf\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><\/a><\/p>\n<\/div>\n<div class=\"mfn-footer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Nanexa AB (publ) h\u00f6ll den 23 oktober 2017 en extra bolagsst\u00e4mma.<\/p>\n","protected":false},"template":"","class_list":["post-3890","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-ci-gm_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn-regulatory-listing_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-gm-info_sv","mfn-news-tag-mfn-regulatory_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Kommunik\u00e9 fr\u00e5n extra bolagsst\u00e4mma i Nanexa AB (publ) den 23 oktober 2017 - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-extra-bolagsstamma-i-nanexa-ab-publ-den-23-oktober-2017\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kommunik\u00e9 fr\u00e5n extra bolagsst\u00e4mma i Nanexa AB (publ) den 23 oktober 2017 - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Nanexa AB (publ) h\u00f6ll den 23 oktober 2017 en extra bolagsst\u00e4mma.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-extra-bolagsstamma-i-nanexa-ab-publ-den-23-oktober-2017\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/kommunike-fran-extra-bolagsstamma-i-nanexa-ab-publ-den-23-oktober-2017\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/kommunike-fran-extra-bolagsstamma-i-nanexa-ab-publ-den-23-oktober-2017\\\/\",\"name\":\"Kommunik\u00e9 fr\u00e5n extra bolagsst\u00e4mma i Nanexa AB (publ) den 23 oktober 2017 - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2017-10-24T07:11:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/kommunike-fran-extra-bolagsstamma-i-nanexa-ab-publ-den-23-oktober-2017\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/kommunike-fran-extra-bolagsstamma-i-nanexa-ab-publ-den-23-oktober-2017\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/kommunike-fran-extra-bolagsstamma-i-nanexa-ab-publ-den-23-oktober-2017\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Kommunik\u00e9 fr\u00e5n extra bolagsst\u00e4mma i Nanexa AB (publ) den 23 oktober 2017\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kommunik\u00e9 fr\u00e5n extra bolagsst\u00e4mma i Nanexa AB (publ) den 23 oktober 2017 - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-extra-bolagsstamma-i-nanexa-ab-publ-den-23-oktober-2017\/","og_locale":"sv_SE","og_type":"article","og_title":"Kommunik\u00e9 fr\u00e5n extra bolagsst\u00e4mma i Nanexa AB (publ) den 23 oktober 2017 - Nanexa AB","og_description":"Nanexa AB (publ) h\u00f6ll den 23 oktober 2017 en extra bolagsst\u00e4mma.","og_url":"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-extra-bolagsstamma-i-nanexa-ab-publ-den-23-oktober-2017\/","og_site_name":"Nanexa AB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-extra-bolagsstamma-i-nanexa-ab-publ-den-23-oktober-2017\/","url":"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-extra-bolagsstamma-i-nanexa-ab-publ-den-23-oktober-2017\/","name":"Kommunik\u00e9 fr\u00e5n extra bolagsst\u00e4mma i Nanexa AB (publ) den 23 oktober 2017 - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2017-10-24T07:11:27+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-extra-bolagsstamma-i-nanexa-ab-publ-den-23-oktober-2017\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/kommunike-fran-extra-bolagsstamma-i-nanexa-ab-publ-den-23-oktober-2017\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-extra-bolagsstamma-i-nanexa-ab-publ-den-23-oktober-2017\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Kommunik\u00e9 fr\u00e5n extra bolagsst\u00e4mma i Nanexa AB (publ) den 23 oktober 2017"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/3890","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=3890"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}